166 related articles for article (PubMed ID: 38629220)
1. Translational Research and Health Equity: Gene Therapies for Sickle Cell Disease as a Case Study.
Majumder MA; Fasipe T
Ethics Hum Res; 2024; 46(3):34-39. PubMed ID: 38629220
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Role of Bioethics in Translational Science.
Rothstein MA
J Law Med Ethics; 2022; 50(3):603-607. PubMed ID: 36398631
[TBL] [Abstract][Full Text] [Related]
3. Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).
Baumann AA; Belle SH; James A; King AA;
BMC Health Serv Res; 2018 Jun; 18(1):500. PubMed ID: 29945631
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease.
Azul M; Vital EF; Lam WA; Wood DK; Beckman JD
Transl Res; 2022 Aug; 246():1-14. PubMed ID: 35354090
[TBL] [Abstract][Full Text] [Related]
5. Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.
Goshua G; Calhoun C; Ito S; James LP; Luviano A; Krishnamurti L; Pandya A
Ann Intern Med; 2023 Jun; 176(6):779-787. PubMed ID: 37247420
[TBL] [Abstract][Full Text] [Related]
6. Seven Strategies to Integrate Equity within Translational Research in Neurology.
Lizarraga KJ; Gyang T; Benson RT; Birbeck GL; Johnston KC; Royal W; Sacco RL; Segal B; Vickrey BG; Griggs RC; Holloway RG
Ann Neurol; 2024 Mar; 95(3):432-441. PubMed ID: 38270253
[TBL] [Abstract][Full Text] [Related]
7. Finding a cure for sickle cell disease.
Makani J
Nat Med; 2019 Dec; 25(12):1811. PubMed ID: 31806888
[No Abstract] [Full Text] [Related]
8. An Updated Equitable Model of Readiness for Transition to Adult Care: Content Validation in Young People With Sickle Cell Disease.
Prussien KV; Crosby LE; Faust HL; Barakat LP; Deatrick JA; Smith-Whitley K; Schwartz LA
JAMA Pediatr; 2024 Mar; 178(3):274-282. PubMed ID: 38190311
[TBL] [Abstract][Full Text] [Related]
9. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
DeWitt MA; Magis W; Bray NL; Wang T; Berman JR; Urbinati F; Heo SJ; Mitros T; Muñoz DP; Boffelli D; Kohn DB; Walters MC; Carroll D; Martin DI; Corn JE
Sci Transl Med; 2016 Oct; 8(360):360ra134. PubMed ID: 27733558
[TBL] [Abstract][Full Text] [Related]
10. Stepping Systematically Forward Toward Health Equity in Sickle Cell Disease.
Marsh AM; Treadwell MJ
JAMA Pediatr; 2024 Mar; 178(3):225. PubMed ID: 38190149
[No Abstract] [Full Text] [Related]
11. Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Basu A; Winn AN; Johnson KM; Jiao B; Devine B; Hankins JS; Arnold SD; Bender MA; Ramsey SD
Ann Intern Med; 2024 Feb; 177(2):155-164. PubMed ID: 38252942
[TBL] [Abstract][Full Text] [Related]
12. Standardizing elements of care in pediatric sickle cell disease centers: The road toward health equity.
Colombatti R
Pediatr Blood Cancer; 2023 Jan; 70(1):e30078. PubMed ID: 36326131
[No Abstract] [Full Text] [Related]
13. An analysis of the NIH-supported sickle cell disease research portfolio.
Gavini N; Hoots WK; Mensah GA; Hanspal M
Blood Cells Mol Dis; 2015 Feb; 54(2):198-205. PubMed ID: 25466208
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of sickle cell disease: Imperfect and yet very informative.
Kamimura S; Smith M; Vogel S; Almeida LEF; Thein SL; Quezado ZMN
Blood Cells Mol Dis; 2024 Jan; 104():102776. PubMed ID: 37391346
[TBL] [Abstract][Full Text] [Related]
15. Research knowledge transfer to improve the care and support of adolescents with sickle cell disease in Ghana.
Poku BA; Pilnick A
Health Expect; 2022 Oct; 25(5):2515-2524. PubMed ID: 35909322
[TBL] [Abstract][Full Text] [Related]
16. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
[TBL] [Abstract][Full Text] [Related]
17. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
[TBL] [Abstract][Full Text] [Related]
18. Pain in sickle cell disease: current and potential translational therapies.
Sagi V; Mittal A; Tran H; Gupta K
Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
[TBL] [Abstract][Full Text] [Related]
20. The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease.
DiMartino LD; Baumann AA; Hsu LL; Kanter J; Gordeuk VR; Glassberg J; Treadwell MJ; Melvin CL; Telfair J; Klesges LM; King A; Wun T; Shah N; Gibson RW; Hankins JS;
Am J Hematol; 2018 Dec; 93(12):E391-E395. PubMed ID: 30203558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
